Published Mar 26, 2019

Abcuro announces pre-clinical data on new immuno-oncology target

Member News
Copy The Link to the  Article
Abcuro announces pre-clinical data on new immuno-oncology target
First in vivo validation of KLRG1 as a new cancer immunotherapy target
Copy The Link to the  Article

Related or similar articles

View more News
March 13, 2019

Labshares Celebrates Grand Opening and Unveils Newly Expanded Shared Office and Lab Space in Newton

Labshares Newton's newly expanded facility features a cutting-edge lab and co-working space that can now accommodate up to 30 startups
Press Releases
December 9, 2021

Bulfinch Leases 40,000 Square Feet to Labshares

BOSTON & NEWTON, Mass.--(BUSINESS WIRE)--The Bulfinch Companies, Inc. (Bulfinch), a commercial real estate and investment firm, and Labshares Newton today announced the expansion of the life science and biotech co-working incubator at Chapel Bridge..
Labshares News
August 8, 2018

Harbour BioMed inks $350 million deal for rights to A167

USA-based Harbour BioMed has entered into an exclusive strategic partnership with China’s Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167
Member News